Intriguingly, genomic sequencing of human BCC revealed that HH/GLI‐driven skin cancers display an exceptionally high mutational burden with an average of 65 mutations per megabase [47], suggesting that BCC is likely to represent an immunogenic cancer entity. This evidence concerns the gene GLI1 and cancer.